Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Conversion of shares in Skanska AB

In conjunction with a conversion of shares, the company is obliged, according to the Financial Instruments Trading Act (1991:980), to disclose information concerning the change.During July 2021, 1,225 Series A shares were converted to Series B shares at the request of shareholders. Accordingly, the total number of votes in the company totals 596,987,990. The total number of registered shares in the company amounts to 419,903,072, of which 19,676,102 are Series A shares, and 400,226,970 are Series B shares.

Raytelligence granted a patent by the USPTO

The United States Patent and Trademark Office (USPTO) has granted Raytelligence the U.S. Patent Number 15/781,594 entitled "RADAR DETECTOR FOR MONITORING OF BODILY FUNCTIONS". The USPTO is the federal agency for granting patents and registering trademarks in the USA and the patent gives the company exclusive rights to the patented technology on the American market for the coming 20 years. "North America is an important market for us and thus we are happy to also have our first patent approved here. This patent is also a proof that parts of our core technology is so innovative that it can

Dividend Payment

30 July 2021 Gulf Keystone Petroleum Ltd. (LSE: GKP)("Gulf Keystone", "GKP" or "the Company")  Dividend Payment   At Gulf Keystone's Annual General Meeting on 18 June 2021, shareholders approved the distribution of a special dividend of $25 million.  The payment is equivalent to 11.697 US cents per Common Share of the Company. It has been converted into pounds sterling at a rate of $1:£0.71618 prevailing on 29 July 2021, and hence a dividend of 8.377p per Common Share will be paid on 6 August 2021 to those shareholders on the register of members of the Company as at 30

NoHo Partners Plc's Q2/2021 Half-year Report briefing on 10 August 2021 at 10 a.m. at Nokka

NoHo Partners Plc INVESTOR NEWS 30 July 2021 at 11:30 NoHo Partners Plc's Q2/2021 Half-year Report briefing on 10 August 2021 at 10 a.m. at Nokka NoHo Partners Plc will publish its Half-year Report for January 1 – June 30, 2021 on Tuesday, 10 August 2021 approximately at 8:15 a.m. Finnish time, after which the Half-year Report is available at www.noho.fi. A briefing for the media, analysts and investors will be organized on Tuesday, 10 August 2021 at 10:00 a.m. at restaurant Nokka, Kanavaranta 7 F, 00160 Helsinki. The presentation about NoHo Partners Plc's Q2/2021 financial

CS MEDICA A/S announces its intention to list its shares on Spotlight Stock Market

CS MEDICA A/S (”CS MEDICA” or the ”Company”) is a Danish medico cannabis company committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids The Company hereby announces its intention to launch an initial public offering of its shares (the “IPO” or the “Offer”) and to list its shares on Spotlight Stock Market (“Spotlight”) in Q3 2021. CS MEDICA has engaged Sedermera Fondkommission to act as financial advisor, Markets & Corporate Law Nordic AB as legal advisor, Nordnet Bank AB as selling agent, and Nordic Issuing to provide

New number of shares and votes in Dustin Group AB (publ)

The number of shares and votes in Dustin has increased by 8,733 as a result of exercise of warrants in accordance with the company’s incentive programs. Today, the last trading day of the month, there are in total 96,958,951 shares and votes in the company. For further information, please contact: Eva Ernfors, Head of Communication: eva.ernfors@dustin.se, +46 702 58 62 94 This is information that Dustin Group AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 09:40 CET on 30 July 2021.

SimCorp A/S – Share buyback program completed

Company Announcement no. 33/2021On February 10, 2021 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 10, 2021 to July 31, 2021. The following transactions have been executed under the program:          Date                 Number of shares

Resolutions of the Extraordinary General Meeting of Tecnotree Corporation

Tecnotree Corporation Stock Exchange Release 30 Jul 2021 at 10:30 EETThe Extraordinary General Meeting of Tecnotree Corporation (the “Company”) was held on 30 July 2021 at 10 a.m. in Espoo. The Extraordinary General Meeting resolved in accordance with the proposal of the Board of Directors to authorize the Board of Directors to decide on a directed share issue based on which a maximum of 30,577,778 new shares may be issued. The shares may be offered in deviation from the Company’s shareholder’ pre-emptive subscription right to be subscribed for by Joensuun Kauppa ja Kone Oy and Oy

Buy-backs of shares of series B in Saab during week 29-30 2021

During the period 23 July – 29 July 2021, Saab AB (publ) (LEI code 549300ZHO4JCQQI13M69) has repurchased in total 444.000 own shares of series B (ISIN: SE0000112385) as part of the share buy-back programme initiated by the Board of Directors in order to secure delivery of shares to participants in Saab’s long-term Share Matching Plan, Performance Share Plan and Special Projects Incentive.The share buy-back programme, which Saab announced on 11 June 2021, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU)

Future Business Update

NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL This announcement does not constitute an offering circular, prospectus or other offer documents. No one should purchase or subscribe for any securities in TROPHY GAMES Development A/S ("TROPHY GAMES" or the "Company") except on the basis of information in the company description published by the Company in connection with the offering and admission of such securities

Joanna Koskinen appointed new employee representative of the Board of Directors of Nordea Bank Abp

Nordea Bank AbpStock exchange release – Changes board/management/auditors30 July 2021 at 09.30 EET Kari Ahola, an ordinary member of the Board of Directors of Nordea Bank Abp appointed by the employees of the Nordea Group, will resign from the Board on 31 July 2021. The employees of the Nordea Group have appointed Joanna Koskinen as an ordinary member of the Board of Directors as of 1 August 2021 until the end of the next Annual General Meeting. Joanna Koskinen, MBA, born in 1977, has worked at Nordea Bank Abp and its predecessors for more than ten years, most recently as a

Change in number of shares and votes in Evolution AB (publ)

In accordance with the decision at the board meeting on 30 June 2021, Evolution AB (publ) has issued 1,105,032 shares to the sellers of Big Time Gaming. Further, in July warrants of series 2018/2021 have been exercised to subscribe for 1,673,340 shares in Evolution AB (publ). As of 30 July 2021, following the new issue of shares and exercise of warrants set out above, the number of shares and votes in Evolution AB (publ) amounts to 215,105,380.

MTG completes the first step of the acquisition of word games developer PlaySimple

STOCKHOLM, July 30, 2021 — Modern Times Group MTG AB (publ) (“MTG”) has completed the first step in the acquisition of the shares in word games developer PlaySimple, which was announced through a press release on 2 July 2021, and has acquired 77% of the shares in PlaySimple.Due to Indian foreign exchange regulations, the acquisition is carried out in two steps. MTG has now completed the first step and has acquired 77 % of the shares in PlaySimple against a consideration of approximately SEK 2,388 million (USD 277 million). The intention is to pay the remaining 23 % of the shares in

NextCell Pharma publishes Interim Report 3 2020/2021

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 2 for the period September 1, 2020 - February 28, 2021 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.  Third quarter (2020-03-01 until 2021-05-31) · Operating income amounted to SEK 905 750 (750 512). · Operating result amounted to SEK -6 457 514 (-4 833 332). · Earnings

Axolot Solutions Holding AB (publ) - Interim report January - June 2021

Axolot sold its second AxoPur® system in quarter two and signed two agreements on in-depth tests and studies with the purpose to provide a basis for the dimensioning of full-size commercial systems.Summary of the second quarter 2021 Financially · Net sales amounted to 529 tSEK (1 019 tSEK for the corresponding quarter in 2020), which refers to trial runs and studies. · Other revenues were 60 tSEK (11), which relates to state subsidies and support. · Earnings before interest and tax became -4 954 tSEK (-5 309). · Net earnings per share amounted to -0,09 SEK (-0,20). ·

CELLINK announces an increase in number of shares and votes

The number of shares and votes in CELLINK AB (publ) (“CELLINK”) have increased as a result of an issue in kind of 262,320 shares of series B which was carried out as a part of the financing for the acquisition of Discover Echo Inc. The Board of Directors resolved on an issue in kind on June 30, 2021 in accordance with the authorization from the Annual General Meeting held on April 26, 2021. Further, 349,000 warrants were exercised pursuant to CELLINK’s warrant programme 2018 for subscription of 349,000 shares of series B. As of July 30, 2021, the total number of registered and

Eisai presented latest data from the lecanemab clinical program at AAIC 2021

Stockholm, July 30, 2021 - BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai held several presentations at the Alzheimer’s Association International Conference (AAIC) in Denver, Colorado July 26 to 30, 2021. The presentations included the latest data for the investigational anti-amyloid beta antibody lecanemab (BAN2401), for which the FDA recently granted Breakthrough Therapy designation.In an oral presentation, baseline characteristics and results from the preliminary screening of the Phase 3 clinical study, AHEAD 3-45, for preclinical (asymptomatic) Alzheimer’s disease, were

New number of shares and votes in Moberg Pharma AB (publ)

STOCKHOLM, July 30[th], 2021, Moberg Pharma AB (OMX: MOB) announced that the total number of common shares in the company has increased to 45,511,425. The 910,000 newly issued shares are held by the company to secure its commitments under incentive programmes.As per July 30[th], 2021, the total number of shares in Moberg Pharma AB (publ) amounts to 45,511,425. All shares are common shares. The total number of votes are 45,511,425. The increase in the number of shares and votes results from an issue of 910,000 class C shares. The newly issued class C shares have been repurchased and, by

Change in the number of shares and votes in John Mattson Fastighetsföretagen AB (publ)

The number of shares and votes in John Mattson Fastighetsföretagen AB (publ) changed in July as a result of the non-cash issue of 1,047,277 new shares in the same month.Under the Swedish Financial Instruments Trading Act (SFS 1991:980), any increase or decrease in the total number of shares or votes in a Swedish listed company whose shares are admitted to trading in a regulated market must be made known by the company as of the last day of trading of the month in question. On 6 July, the Board of Directors of John Mattson decided to issue a total of 1,047,277 new shares as part payment

Conversion of shares

According to SCA’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner. In July, at the request of shareholders 3 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,283,625,435.The total number of registered shares in the company amounts to 702,342,489 of which 64,586,994 are Class A shares

Change in the total number of shares and votes in Knowit

As of July 30, 2021, the total number of shares and votes in Knowit amounts to 27,408,600.The number of shares and votes in Knowit has increased as a result of the registration of 5,760,883 shares, which in accordance with previously published information was issued in connection with the non-cash issue carried out by the company on July 1, 2021.   This information is published in accordance with Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act (SFS 1991:980). This press release was made public, through the agency of the persons below, at 8 am CEST on 30 July 2021.

Segulah Medical Acceleration Announces Investment in Signifier Medical Technologies

Segulah Medical Acceleration AB (SMA) announced today that it has invested in UK-based Signifier Medical Technologies’ USD 35 million Series D convertible financing. The financing was jointly led by SMA together with Angelus Venture Fund I L.P., Alan Howard (co-founder of Brevan Howard Asset Management) and Pioneer Healthcare Partners LP.Signifier is commercializing proprietary technologies to address the root causes of sleep disordered breathing and are focused on the development of innovative and non-invasive solutions for patients with conditions such as obstructive sleep apnoea (OSA)

There are no items matching the current filter
There are no more items matching the current filter
Back to top